Automating NGS Workflows for the Analysis of Rare Diseases

Genuity Science Experience
first slide

More about NGS in the Dx of Rare Diseases

Webinar description

In this Webinar, Dr. George Penman, Principal Scientist Automation at Genuity Science, describes the automation journey that his company has followed to achieve its current sequencing capabilities. Moreover, Dr. Ben Molloy, Clinical Research Scientist, discusses the challenges and achievements of the Rare Disease Program that Genuity Science carries out, in collaboration with Children's Health Ireland.

At the conclusion of the Webinar, Dr. Clare Logan and Dr. Gabriela Boza-Moran  present some of the commercial solutions that Illumina and Hamilton Robotics can provide to customers using NGS in the diagnosis of rare diseases.



 George Penman



Dr. George Penman

Principal Scientist Automation - Genuity Science


 ben mollowy 2



Dr. Ben Molloy

Clinical Research Scientist - Genuity Science




Dr. Clare Logan

Staff Field Application Scientist - Illumina


Gabriela Boza-Moran


Dr. Gabriela Boza-Moran
Scientific Content Manager - Hamilton Robotics